Taiwan: Hilterapia® and baseball - a successful combination

27 May 2019 - Corporate -

A place of honour for Hilterapia® and the SH1 device in the professional baseball league in Taiwan.
ASA’s therapy was in fact employed to treat the player in the Unilions team who won the MVP award (the award given to the Most Valuable Player during the baseball league).

“A new significant confirmation of the winning partnership between Hilterapia® and sports: thanks also to our therapy – as Giacomo Granozio, ASA’s Export Area Manager specifies – the most representative athlete on the Taiwanese Unilions baseball team was able not just to get back on to the pitch, but also to help achieve two consecutive victories for his team!”.

You might also be interested in ...

See all articles

Fisioterapia in ASAlaser
News - 15/10/2024
For the “European Week for Safety and Health at Work” (21/25 October) ASA has implemented some targeted initiatives for its collaborators.
ASA Welfare
News - 04/09/2024
ASA focuses on Welfare by means of a wide-ranging plan which aims to provide value to internal resources and to provide then with opportunities to improve the professionality and quality of their day...
ASA Partners Meeting 2024
News - 21/03/2024
Four days of full immersion in the world of ASA to focus on the new devices - M-Hi and HIRO – and to analyse the biological effects of Hilterapia®.
Hilterapia and nerve function
Blog - 04/11/2024
A recent study conducted by Alayat et al. (2024) is the first to examine the effects of Hilterapia® - pulsed Nd:YAG laser source (1064nm) - on skin temperature and nerve function in healthy...
MLS Laser Therapy Speech in Brasov, Romania
News - 30/10/2024
MLS® Laser Therapy and some of its flagship devices could not miss out on attending the “National Congress of Physical Medicine and Rehabilitation” in Brasov (Romania, 16-19 October).
ASA laser therapies speech at Rehabilitaja
News - 29/10/2024
A corner dedicated to the HIRO, M-Hi and M6 devices in the exhibition space of the Polish distributor Meden Inmed and two speeches.